Form EFFECT Agomab Therapeutics NV
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:01 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lovense Launches Match Intensity, Turning World Cup Excitement Into Real-Time Sensory Feedback In Its Ecosystem
- Best Crypto Presale to Buy: Pepeto’s $10.3M Raise Signals Listing Power Over SOL’s Recovery
- Render Price Prediction After 89% Decline While Pepeto Presale Offers a Different Path
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
